130 related articles for article (PubMed ID: 8005187)
1. Kinetic interaction between theophylline and a newly developed anti-allergic drug, pemirolast potassium.
Hasegawa T; Takagi K; Nadai M; Ogura Y; Nabeshima T
Eur J Clin Pharmacol; 1994; 46(1):55-8. PubMed ID: 8005187
[TBL] [Abstract][Full Text] [Related]
2. Effect of mequitazine on the pharmacokinetics of theophylline in asthmatic patients.
Hasegawa T; Takagi K; Kuzuya T; Nadai M; Apichartpichean R; Muraoka I
Eur J Clin Pharmacol; 1990; 38(3):255-8. PubMed ID: 2340844
[TBL] [Abstract][Full Text] [Related]
3. Kinetic interaction between theophylline and a newly developed quinolone, NY-198.
Kuzuya T; Takagi K; Apichartpichean R; Muraoka I; Nadai M; Hasegawa T
J Pharmacobiodyn; 1989 Jul; 12(7):405-9. PubMed ID: 2593082
[TBL] [Abstract][Full Text] [Related]
4. Effect of a new quinolone, sparfloxacin, on the pharmacokinetics of theophylline in asthmatic patients.
Takagi K; Yamaki K; Nadai M; Kuzuya T; Hasegawa T
Antimicrob Agents Chemother; 1991 Jun; 35(6):1137-41. PubMed ID: 1929255
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies on interaction between theophylline and quinolones.
Takagi K; Hasegawa T; Ogura Y; Suzuki R; Yamaki K; Watanabe T; Kitazawa S; Satake T
J Asthma; 1988; 25(2):63-71. PubMed ID: 3182580
[TBL] [Abstract][Full Text] [Related]
6. Interaction between theophylline and enoxacin.
Takagi K; Hasegawa T; Yamaki K; Suzuki R; Watanabe T; Satake T
Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):288-92. PubMed ID: 3165968
[TBL] [Abstract][Full Text] [Related]
7. [Effects of antiallergic drug, pemirolast potassium on phospholipase D activation in antigen-stimulated rat basophilic leukemia (RBL-2H3) cells].
Nakamura Y; Nakashima S; Fujimiya H; Kumada T; Ojio K; Miyata H; Nozawa Y
Arerugi; 1995 Jun; 44(6):624-9. PubMed ID: 7669001
[TBL] [Abstract][Full Text] [Related]
8. Immunopharmacological studies on TBX, a new antiallergic drug (4). Effects on type II to IV allergic reactions and immunological functions in animal models.
Yanagihara Y; Kasai H; Kawashima T; Ninomiya K
Jpn J Pharmacol; 1989 Sep; 51(1):93-100. PubMed ID: 2530379
[TBL] [Abstract][Full Text] [Related]
9. Effects of an antiallergic drug, pemirolast potassium on tyrosine phosphorylation and map kinase activation in antigen-stimulated rat basophilic leukemia (RBL-2H3) cells.
Nakamura Y; Nakashima S; Fujimiya H; Kumada T; Kato Y; Miyata H; Nozawa Y
Arerugi; 1995 Jan; 44(1):34-44. PubMed ID: 7702453
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of repirinast on the pharmacokinetics of theophylline in asthmatic patients.
Takagi K; Kuzuya T; Horiuchi T; Nadai M; Apichartpichean R; Ogura Y; Hasegawa T
Eur J Clin Pharmacol; 1989; 37(3):301-3. PubMed ID: 2558890
[TBL] [Abstract][Full Text] [Related]
11. Immunopharmacological studies on TBX, a new antiallergic drug (3). Inhibitory effects on histamine release from lung fragments and bronchoconstriction in guinea pigs.
Yanagihara Y; Kasai H; Matsui S; Ninomiya K
Jpn J Pharmacol; 1989 Sep; 51(1):83-92. PubMed ID: 2478743
[TBL] [Abstract][Full Text] [Related]
12. Temelastine does not affect theophylline pharmacokinetics in normal subjects.
Charles BG; Schneider JJ; Norris RL; Ravenscroft PJ
Br J Clin Pharmacol; 1987 Nov; 24(5):673-5. PubMed ID: 2893638
[TBL] [Abstract][Full Text] [Related]
13. Effect of zileuton on theophylline pharmacokinetics.
Granneman GR; Braeckman RA; Locke CS; Cavanaugh JH; Dubé LM; Awni WM
Clin Pharmacokinet; 1995; 29 Suppl 2():77-83. PubMed ID: 8620674
[TBL] [Abstract][Full Text] [Related]
14. An antiallergic drug, pemirolast potassium, inhibits inositol 1,4,5-trisphosphate production and Ca2+ mobilization in antigen-stimulated rat basophilic leukemia (RBL-2H3) cells.
Fujimiya H; Nakashima S; Kumada T; Nakamura Y; Miyata H; Nozawa Y
Arerugi; 1994 Feb; 43(2 Pt 1):142-51. PubMed ID: 8147717
[TBL] [Abstract][Full Text] [Related]
15. Theophylline steady state pharmacokinetics is not altered by omeprazole.
Taburet AM; Geneve J; Bocquentin M; Simoneau G; Caulin C; Singlas E
Eur J Clin Pharmacol; 1992; 42(3):343-5. PubMed ID: 1577056
[TBL] [Abstract][Full Text] [Related]
16. [Suppression of conjunctival provocation by 0.1% pemirolast potassium ophthalmic solution in VKC].
Nakagawa Y; Jikuhara Y; Higasida M; Yuasa T
Arerugi; 1994 Dec; 43(12):1405-8. PubMed ID: 7535044
[No Abstract] [Full Text] [Related]
17. Coadministration with lopinavir and ritonavir decreases exposure to BILR 355, a nonnucleoside reverse transcriptase inhibitor, in healthy volunteers.
Huang F; Scholl P; Huang DB; MacGregor TR; Vinisko R; Castles MA; Berger F; Robinson P
J Clin Pharmacol; 2011 Jul; 51(7):1061-70. PubMed ID: 20705951
[TBL] [Abstract][Full Text] [Related]
18. Absence of effect of rufloxacin on theophylline pharmacokinetics in steady state.
Kinzig-Schippers M; Fuhr U; Cesana M; Müller C; Staib AH; Rietbrock S; Sörgel F
Antimicrob Agents Chemother; 1998 Sep; 42(9):2359-64. PubMed ID: 9736563
[TBL] [Abstract][Full Text] [Related]
19. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
[TBL] [Abstract][Full Text] [Related]
20. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
Götz J; Sauter R; Steinijans VW; Jonkman JH
Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
